September 2, 2026

Beyond AI-Enabled: Why a New Partner Model Is Vital for Pharmaceutical Marketing in Europe

European pharmaceutical marketers are navigating a uniquely complex landscape, balancing diverse healthcare systems, regulatory environments and market-specific needs. As AI continues to transform commercialization, the conversation must move beyond efficiency gains and automation toward a more fundamental question: what should the future client-agency partnership look like?

In this POV, Michael Le Brocq, Global Head of Strategy, explores how AI is reshaping traditional agency models and creating opportunities for a more intelligent, orchestrated approach to commercialization across Europe. Discover the role of responsible AI, the impact of evolving European regulations and why human judgment, strategic expertise, and outcomes-driven partnerships will become increasingly valuable in an AI-enabled future.

Download the POV to discover how pharmaceutical organizations can harness AI to achieve European-scale intelligence while delivering market-level relevance.

Download the POV

Submit Your Details to Access the Content